Piper Sandler Maintains Neutral on Fulgent Genetics, Raises Price Target to $25

Benzinga · 2d ago
Piper Sandler analyst David Westenberg maintains Fulgent Genetics (NASDAQ:FLGT) with a Neutral and raises the price target from $19 to $25.